To examine whether repression of CD44 levels would increase the drug sensitivity of ovarian cancer cells, the MTT assay was performed on the established cell lines OVCAR8Lentivirus only, OVCAR8Non-specific shRNA, and OVCAR8CD44 shRNA after incubating with paclitaxel. Here, CD44 is linked to ovarian cancer.